Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing levothyroxine sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 50 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 175 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 300 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 88 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 112 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 137 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 0.05mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 0.075mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 0.088mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 0.1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 0.112mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 0.15mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 0.175mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 0.125mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 0.2mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 0.3mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium o.05mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 0.15mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 0.025mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 200mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Liotrix preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing levothyroxine sodium and liothyronine sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
intoxication accidentelle par la lévothyroxine sodique |
Causative agent (attribute) |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
intoxication intentionnelle par la lévothyroxine sodique |
Causative agent (attribute) |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
intoxication par la lévothyroxine sodique d'intention indéterminée |
Causative agent (attribute) |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
intoxication par la lévothyroxine sodique |
Causative agent (attribute) |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 50 microgram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Levothyroxine sodium 125 microgram oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing levothyroxine sodium in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 50 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 50 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 175 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 175 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 300 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 300 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 88 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 88 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 112 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 112 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 137 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 137 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 250 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
2 |
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
2 |
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
2 |
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
2 |
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 50 microgram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 50 microgram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 125 microgram oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 125 microgram oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
2 |
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
2 |
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
2 |
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
2 |
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
2 |
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
2 |
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
2 |
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
2 |
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Levothyroxine sodium |
Inferred relationship |
Some |
1 |